Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 1.00 |
| ▸ | HTR1A | P08908 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | DRD2 | P14416 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | DRD4 | P21917 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | DRD3 | P35462 | 1/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.76 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.76 |
| ▸ | APEX1 | P27695 | 1/20 | 0.76 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.76 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.76 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Roxindole SCHEMBL5605611 | 1.00 | TDP1 (1.00) | TDP1HTR1ACYP1A2CYP3A4MAPT | |
| Roxindole SCHEMBL5453647 | 0.99 | TDP1 (0.98) | TDP1HTR1ACYP1A2CYP3A4MAPT | |
| Roxindole SCHEMBL677639 | 0.94 | TDP1 (0.88) | TDP1HTR1ACYP1A2CYP3A4MAPT | |
| Roxindole SCHEMBL29489916 | 0.94 | TDP1 (0.88) | TDP1HTR1ACYP1A2CYP3A4MAPT | |
| SCHEMBL10355142 | 0.92 | TDP1 (0.85) | TDP1HTR1ACYP1A2CYP3A4MAPT | |
| SCHEMBL9582399 | 0.88 | TDP1 (0.79) | TDP1HTR1ACYP1A2CYP3A4MAPT | |
| Carmoxirole SCHEMBL5606162 | 0.87 | TDP1 (0.98) | TDP1HTR1ACYP1A2CYP3A4MAPT | |
| Carmoxirole SCHEMBL31723392 | 0.87 | TDP1 (0.98) | TDP1HTR1ACYP1A2CYP3A4MAPT | |
| Carmoxirole SCHEMBL146312 | 0.87 | TDP1 (0.98) | TDP1HTR1ACYP1A2CYP3A4MAPT | |
| SCHEMBL9581606 | 0.86 | TDP1 (0.96) | TDP1HTR1ACYP1A2CYP3A4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2570 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4717276-A2 | OPHTHALMIC COMPOSITIONS COMPRISING LEVODOPA, AN ANTIOXIDANT AND AN AQUEOUS CARRIER | University of Canberra (AU) | 2026-04-01 | — | — | EP | claimed |
| EP-3442516-B1 | OPHTHALMIC COMPOSITIONS COMPRISING LEVODOPA, AN ANTIOXIDANT AND AN AQUEOUS CARRIER | UNIV CANBERRA (AU) | 2025-11-12 | — | — | EP | claimed |
| US-20250295611-A1 | METHODS OF TREATING 5HT2A RECEPTOR-MEDIATED CONDITIONS | TESSELLATE THERAPEUTICS INC (US) | 2025-09-25 | — | — | US | claimed |
| EP-4618976-A1 | COMPOSITIONS AND METHODS OF TREATING NEUROLOGICAL CONDITIONS | Dri Biosciences Corporation (US) | 2025-09-24 | — | — | EP | claimed |
| WO-2025151884-A1 | USE OF GLYCOSAMINOGLYCAN SULFATED POLYSACCHARIDES SUCH AS SODIUM PENTOSAN POLYSULFATE IN COMBINATION WITH PERMEATION AGENTS TO TREAT ALZHEIMER'S DISEASE | PARSONS C LOWELL (US) | 2025-07-17 | — | — | WO | claimed |
| EP-4558622-A1 | METHODS AND COMPOSITIONS FOR GENERATING HUMAN MIDBRAIN DOPAMINERGIC NEURONS FROM NEURAL PROGENITOR CELLS | Trailhead Biosystems Inc. (US) | 2025-05-28 | — | — | EP | claimed |
| WO-2024107961-A1 | COMPOSITIONS AND METHODS OF TREATING NEUROLOGICAL CONDITIONS | DRI BIOSCIENCES CORPORATION (US) | 2024-05-23 | — | — | WO | claimed |
| US-20240117303-A1 | METHODS AND COMPOSITIONS FOR GENERATING HUMAN MIDBRAIN DOPAMINERGIC NEURONS FROM NEURAL PROGENITOR CELLS | TRAILHEAD BIOSYSTEMS INC. | 2024-04-11 | — | — | US | claimed |
| EP-4335504-A2 | TREATMENT OF MOVEMENT DISORDERS | Contera Pharma ApS (DK) | 2024-03-13 | — | — | EP | claimed |
| US-11890266-B2 | Ophthalmic compositions including levodopa, an antioxidant and an aqueous carrier | UNIVERSITY OF CANBERRA (AU) | 2024-02-06 | — | — | US | claimed |
| WO-2002036113-A1 | COMPOSITION COMPRISING: SEROTONIN RECEPTOR ANTAGONISTS (5HT-2, 5HT-3) AND AGONIST (5HT-4) | RESPIRATORIUS AB (SE) | 2002-05-10 | — | — | WO | claimed |
| WO-2002036114-A1 | COMPOSITION COMPRISING SEROTONIN RECEPTOR ANTAGONISTS, 5 HT-2 AND 5 HT-3 | RESPIRATORIUS AB (SE) | 2002-05-10 | — | — | WO | claimed |
| WO-2002030422-A1 | USE OF DEFINED SUBSTANCES THAT BIND TO THE SIGMA RECEPTOR FOR COMBATING SARCOMA AND CARCINOMA | MERCK PATENT GMBH (DE) | 2002-04-18 | — | — | WO | claimed |
| EP-1173168-A2 | COMPOUND FOR USE AS A MEDICAMENT FOR TREATMENT OF DISORDERS INVOLVING BRONCHOCONTRACTION | Respiratorius AB (SE) | 2002-01-23 | — | — | EP | claimed |
| WO-2000064441-A2 | COMPOUND FOR USE AS A MEDICAMENT FOR TREATMENT OF DISORDERS INVOLVING BRONCHOCONTRACTION | RESPIRATORIUS AB (SE) | 2000-11-02 | — | — | WO | claimed |
| US-6127349-A | Phospholipid drug derivatives | AMUR RESEARCH CORPORATION (US) | 2000-10-03 | — | — | US | claimed |
| EP-0948341-A1 | PHOSPHOLIPID DRUG DERIVATIVES | Amur Pharmaceuticals, Inc. (US) | 1999-10-13 | — | — | EP | claimed |
| WO-1998011906-A1 | PHOSPHOLIPID DRUG DERIVATIVES | AMUR PHARMACEUTICALS, INC. (US) | 1998-03-26 | — | — | WO | claimed |
| EP-0281608-A1 | HYDROXYLINDOL DERIVATIVES. | MERCK PATENT GMBH (DE) | 1988-09-14 | — | — | EP | claimed |
| WO-1988001998-A1 | HYDROXYLINDOL DERIVATIVES | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1988-03-24 | — | — | WO | claimed |